April 7, 2022
Benefits of AI in preclinical studies
The preclinical phase of drug discovery involves extensive safety evaluations of the potential therapeutic intervention, often using cell and animal models of disease. These studies commonly include going through numerous histopathological samples. This contributes to the drug development process being time-consuming and labor-intensive for pharmaceutical and contract research organizations.
Written by Aiforia